Comparison of Two Methods for Bowel Preparation in Patients With Constipation
- Conditions
- Health Behavior
- Interventions
- Drug: Split dose of 4L PEGDrug: Three times dose of 4L PEG
- Registration Number
- NCT03306030
- Lead Sponsor
- Air Force Military Medical University, China
- Brief Summary
Constipation is a common high risk factor for inadequate bowel preparation. The bowel cleansing efficacy of the standard split-does of 4L seems to be suboptimal in constipated patients. The investigator hypothesized that compared with the standard preparation regime, the split-dose with three times of 4L PEG may be superior in BP quality.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 140
- Patients aged 18-80 with constipation.
- History of colorectal surgery BMI>30 Suspected colonic stricture or bowel obstruction Use of purgatives within 3 days Pregnancy or lactation Unable to give informed consent Haemodynamically unstable
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Split group Split dose of 4L PEG Split-dose of 4l PEG was used before and on the day of colonoscopy Three times group Three times dose of 4L PEG Three times-dose of 4l PEG was used before and on the day of colonoscop of 4l PEG was used before and on the day of colonoscopy
- Primary Outcome Measures
Name Time Method Rate of adequate bowel preparation 1 year Adequacy of bowel preparation quality was defined as a total score ≥6 and each segmental score ≥2. The total scores included 3 scores of colonic regions: the right side, the transverse section, and the left side, which ranged from 0 to 9 (0= very poor, 9=excellent). For the unreached colon in incomplete colonoscopy, the segmental BBPS was scored as 0. The total and segmental scores were judged through videos by investigators who were familiar with the criteria and blinded to group allocation.
- Secondary Outcome Measures
Name Time Method Polyps detection rate 1 year Withdrawal time 1 year Adverse event rate 1 year Cecal intubation rate 1 year Cecal intubation time 1 year
Trial Locations
- Locations (1)
Endoscopic center, Xijing Hospital of Digestive Diseases
🇨🇳Xi'an, China